Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Andrea Bacigalupo, Elisabetta Metafuni, Viviana Amato, Ester Marquez Algaba & Livio Pagano. (2020) Reducing infectious complications after allogeneic stem cell transplant. Expert Review of Hematology 13:11, pages 1235-1251.
Read now
Read now
Olga Zajac-Spychala, Jacek Wachowiak, Anna Szmydki-Baran, Lukasz Hutnik, Malgorzata Salamonowicz, Michal Matysiak, Krzysztof Czyzewski, Mariusz Wysocki, Patrycja Zalas-Wiecek, Zofia Malas, Wanda Badowska, Olga Gryniewicz-Kwiatkowska, Aneta Czajnska-Deptuła, Elwira Kulicka, Bozenna Dembowska-Baginska, Danuta Perek, Katarzyna Semczuk, Katarzyna Dzierzanowska-Fangrat, Tomasz Ociepa, Magdalena Bartnik, Liliana Chelmecka-Wiktorczyk, Walentyna Balwierz, Joanna Klepacka, Nina Irga-Jaworska, Ewa Bien, Elzbieta Adamkiewicz-Drozynska, Agnieszka Urbanek-Dadela, Grazyna Karolczyk, Filip Pierlejewski, Wojciech Mlynarski, Marcin Plonowski, Maryna Krawczuk-Rybak, Weronika Stolpa, Grazyna Sobol, Renata Tomaszewska, Tomasz Szczepanski, Zuzanna Gamrot, Mariola Woszczyk, Maria Wieczorek, Jerzy Kowalczyk & Jan Styczynski. (2019) Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology. Leukemia & Lymphoma 60:1, pages 124-132.
Read now
Read now
Andrew I.T. Hebbard, Monica A. Slavin, Caroline Reed, Benjamin W. Teh, Karin A. Thursky, Jason A. Trubiano & Leon J. Worth. (2016) The epidemiology of Clostridium difficile infection in patients with cancer. Expert Review of Anti-infective Therapy 14:11, pages 1077-1085.
Read now
Read now
Mayu Hikone, Yusuke Ainoda, Sayaka Tago, Takahiro Fujita, Yuji Hirai, Kaori Takeuchi & Kyoichi Totsuka. (2015) Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital. Clinical and Experimental Gastroenterology 8, pages 191-196.
Read now
Read now
Angela Vassallo, Mai-Chi N Tran & Ellie JC Goldstein. (2014) Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Review of Anti-infective Therapy 12:9, pages 1087-1102.
Read now
Read now
Rebecca Campbell, Bonnie Dean, Brian Nathanson, Tracy Haidar, Marcie Strauss & Sheila Thomas. (2013) Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea. Journal of Medical Economics 16:3, pages 440-448.
Read now
Read now
Christos I. Kosmidis & Pranatharthi H. Chandrasekar. (2012) Management of gram-positive bacterial infections in patients with cancer. Leukemia & Lymphoma 53:1, pages 8-18.
Read now
Read now
Articles from other publishers (60)
Pedro Puerta-Alcalde, Carolina Garcia-Vidal & Alex Soriano. (2023) Prevention and treatment of C. difficile in cancer patients. Current Opinion in Infectious Diseases 36:6, pages 473-480.
Crossref
Crossref
Parul Berry & Sahil Khanna. (2023) Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies. BioDrugs 37:6, pages 757-773.
Crossref
Crossref
Yiting Li, Haifeng Cai, Daniel A. Sussman, Jean Donet, Kevin Dholaria, Jiajia Yang, Ami Panara, Ryan Croteau & Jamie S. Barkin. (2021) Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 67:8, pages 3890-3903.
Crossref
Crossref
M. I. Akhmedov, G. A. Klyasova & E. N. Parovichnikova. (2022) Infectious complications and their contributing risk factors after allogeneic hematopoietic stem cell transplantation. Russian journal of hematology and transfusiology 67:1, pages 90-107.
Crossref
Crossref
Bojana Milenković, Vesna Šuljagić, Aneta Perić, Viktorija Dragojević-Simić, Olivera Tarabar, Milomir Milanović, Vesna Putić, Diana Tomić, Branislava Miljković & Sandra Vezmar Kovačević. (2022)
Outcomes of
Clostridioides difficile
infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study
. European Journal of Hospital Pharmacy 29:e1, pages e15-e22.
Crossref
Crossref
Naoya Itoh, Nana Akazawa, Eri Kanawaku, Hiromi Murakami, Yuichi Ishibana, Daichi Kawamura, Takanori Kawabata, Keita Mori, Eiichi N. Kodama & Norio Ohmagari. (2022) Effects of infectious disease consultation and antimicrobial stewardship program at a Japanese cancer center: An interrupted time-series analysis. PLOS ONE 17:1, pages e0263095.
Crossref
Crossref
Renan Gomes do Nascimento, Nataly Any Barros Garrido de Paula, MérciaPatrícia Ferreira Conceição, Daniel Rodrigues de Bastos & Danilo de Oliveira Cerqueira. 2022. The Golden Guide to Oncologic Pharmacy. The Golden Guide to Oncologic Pharmacy
473
513
.
Daniel N Willis, Frederick S Huang, Alexis M Elward, Ningying Wu, Brianna Magnusen, Erik R Dubberke & Robert J Hayashi. (2021)
Clostridioides difficile
Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes
. Journal of the Pediatric Infectious Diseases Society 10:3, pages 302-308.
Crossref
Crossref
Henning Sommermeyer & Jacek PiątekHenning Sommermeyer & Jacek Piątek. 2021. Clostridioides difficile. Clostridioides difficile
49
59
.
Arjun Khunger & Bassam Estfan. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
29
50
.
Massimo Sartelli, Stefano Di Bella, Lynne V. McFarland, Sahil Khanna, Luis Furuya-Kanamori, Nadir Abuzeid, Fikri M. Abu-Zidan, Luca Ansaloni, Goran Augustin, Miklosh Bala, Offir Ben-Ishay, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria E. Cocuz, Raul Coimbra, Francesco Cortese, Yunfeng Cui, Jacek Czepiel, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina M. Dumitru, Christian Eckmann, Edward H. Eiland, Joseph D. Forrester, Gustavo P. Fraga, Jean L. Frossard, Donald E. Fry, Rita Galeiras, Wagih Ghnnam, Carlos A. Gomes, Ewen A. Griffiths, Xavier Guirao, Mohamed H. Ahmed, Torsten Herzog, Jae Il Kim, Tariq Iqbal, Arda Isik, Kamal M. F. Itani, Francesco M. Labricciosa, Yeong Y. Lee, Paul Juang, Aleksandar Karamarkovic, Peter K. Kim, Yoram Kluger, Ari Leppaniemi, Varut Lohsiriwat, Gustavo M. Machain, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick A. Moore, Carlos A. Ordoñez, Leonardo Pagani, Nicola Petrosillo, Francisco Portela, Kemal Rasa, Miran Rems, Boris E. Sakakushev, Helmut Segovia-Lohse, Gabriele Sganga, Vishal G. Shelat, Patrizia Spigaglia, Pierre Tattevin, Cristian Tranà, Libor Urbánek, Jan Ulrych, Pierluigi Viale, Gian L. Baiocchi & Fausto Catena. (2019) 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World Journal of Emergency Surgery 14:1.
Crossref
Crossref
Mini Kamboj, Renee L. Gennarelli, Jennifer Brite, Kent Sepkowitz & Allison Lipitz-Snyderman. (2019)
Risk for
Clostridiodes difficile
Infection among Older Adults with Cancer
. Emerging Infectious Diseases 25:9.
Crossref
Crossref
Zachary I. Willis, Maribeth R. Nicholson, Adam J. Esbenshade, Meng Xu, James C. Slaughter, Debra L. Friedman, Kathryn M. Edwards & Maria C. Di Pentima. (2019) Intensity of Therapy for Malignancy and Risk for Recurrent and Complicated Clostridium difficile Infection in Children. Journal of Pediatric Hematology/Oncology 41:6, pages 442-447.
Crossref
Crossref
Thais Larrainzar-Coghen, Dolors Rodríguez-Pardo, Pere Barba, Juan Aguilar-Company, Virginia Rodríguez, Gloria Roig, Carmen Ferrer, Isabel Ruiz-Camps & Benito Almirante. (2018) Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study. European Journal of Clinical Microbiology & Infectious Diseases 37:11, pages 2075-2082.
Crossref
Crossref
Mahmoud AbdEl-Mongy, Said El-Feky, Heba Masoud & Amira El-Hendi. (2018) Rapid Assays for Detection of Clostridium difficile and Its Toxins in Hospitalized Patients. Journal of Pure and Applied Microbiology 12:3, pages 1247-1254.
Crossref
Crossref
Aaron Fisher, Pradeep Khanal, Ewa Gniado, Leila Khaddour, Molly Orosey, Ismail Hader, Siddhartha Yadav & Alexandra Halalau. (2018)
A Retrospective Study Analyzing the Appropriateness of Initial Treatment of
Clostridium difficile
in Patients with Active Malignancy
. Gastroenterology Research and Practice 2018, pages 1-8.
Crossref
Crossref
A. Ramos Martínez, I. Pintos Pascual & E. Múñez Rubio. (2018) Infecciones en el paciente inmunocomprometido (I). Paciente neutropénico. Tratamiento esteroideo y otros inmunosupresores. Medicine - Programa de Formación Médica Continuada Acreditado 12:55, pages 3237-3244.
Crossref
Crossref
D.A. Álvarez-Hernández, A.M. González-Chávez, D. González-Hermosillo-Cornejo, G.A. Franyuti-Kelly, A. Díaz-Girón-Gidi & R. Vázquez-López. (2018) Present and past perspectives on Clostridium difficile infection. Revista de Gastroenterología de México (English Edition) 83:1, pages 41-50.
Crossref
Crossref
D.A. Álvarez-Hernández, A.M. González-Chávez, D. González-Hermosillo-Cornejo, G.A. Franyuti-Kelly, A. Díaz-Girón-Gidi & R. Vázquez-López. (2018) Perspectivas históricas y vigentes sobre la infección por Clostridium difficile. Revista de Gastroenterología de México 83:1, pages 41-50.
Crossref
Crossref
Cecília Leite Costa, Cibele Barreto Mano de Carvalho, Rafael Holanda González, Markus Andret Cavalcante Gifoni, Ronaldo de Albuquerque Ribeiro, Carlos Quesada-Gómez & Gerly Anne de Castro Brito. (2017) Molecular epidemiology of Clostridium difficile infection in a Brazilian cancer hospital. Anaerobe 48, pages 232-236.
Crossref
Crossref
Andrew W. Chao, Micah Bhatti, Herbert L. DuPont, James P. Nataro, Lily G. Carlin & Pablo C. Okhuysen. (2017) Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagnostic Microbiology and Infectious Disease 89:3, pages 235-240.
Crossref
Crossref
Katherine J. Cotter, Yunhua Fan, Gretchen K. Sieger, Christopher J. Weight & Badrinath R. Konety. (2017) Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy. Bladder Cancer 3:4, pages 305-310.
Crossref
Crossref
Edwin Vargas, Senu Apewokin & Rajat Madan. (2017) Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection. Anaerobe 45, pages 101-105.
Crossref
Crossref
B.J. Brinda, Y. Pasikhova, R.E. Quilitz, C.M. Thai & J.N. Greene. (2017) Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections. Journal of Hospital Infection 95:4, pages 426-432.
Crossref
Crossref
Gianmauro Numico, Vittorio Fusco, Pierfrancesco Franco & Fausto Roila. (2017) Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use. Critical Reviews in Oncology/Hematology 111, pages 144-151.
Crossref
Crossref
Yi Zheng, Yun Luo, Yinxiang Lv, Chen Huang, Qinsong Sheng, Peng Zhao, Julian Ye, Weiqin Jiang, Lulu Liu, Xiaojun Song, Zhou Tong, Wenbin Chen, Jianjiang Lin, Yi-Wei Tang, Dazhi Jin & Weijia Fang. (2017) Clostridium difficile colonization in preoperative colorectal cancer patients. Oncotarget 8:7, pages 11877-11886.
Crossref
Crossref
Sol del Mar Aldrete, Colleen S. Kraft, Matthew J. Magee, Austin Chan, Don Hutcherson, Amelia A. Langston, Brian I. Greenwell, Eileen M. Burd & Rachel Friedman‐Moraco. (2017)
Risk factors and epidemiology of
C
lostridium difficile
infection in hematopoietic stem cell transplant recipients during the peritransplant period
. Transplant Infectious Disease 19:1.
Crossref
Crossref
Mohamad El-Zaatari & John Y. Kao. (2017) Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease. Frontiers in Immunology 8.
Crossref
Crossref
M. S. Chung, J. Kim, J. O. Kang & H. Pai. (2016) Impact of malignancy on Clostridium difficile infection. European Journal of Clinical Microbiology & Infectious Diseases 35:11, pages 1771-1776.
Crossref
Crossref
O. Zając-Spychała, J. Wachowiak, A. Pieczonka, K. Siewiera, J. Frączkiewicz, K. Kałwak, E. Gorczyńska, A. Chybicka, K. Czyżewski, K. Jachna-Sawicka, M. Wysocki, J. Klepacka, J. Goździk, A. Zaucha-Prażmo, J.R. Kowalczyk & J. Styczyński. (2016) Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation. Transplant Infectious Disease 18:5, pages 690-698.
Crossref
Crossref
Alberto Cózar-Llistó, Antonio Ramos-Martinez & Javier Cobo. (2016) Clostridium difficile Infection in Special High-Risk Populations. Infectious Diseases and Therapy 5:3, pages 253-269.
Crossref
Crossref
N. Esther Babady. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
735
758
.
Deirdre L. Church. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
493
535
.
Deirdre L. Church. (2016) Selected Topics in Anaerobic Bacteriology. Microbiology Spectrum 4:4.
Crossref
Crossref
Linda A. Selvey, Claudia Slimings, David J. L. Joske & Thomas V. Riley. (2016) Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study. PLOS ONE 11:6, pages e0157839.
Crossref
Crossref
N. Esther Babady. (2016) Hospital-Associated Infections. Microbiology Spectrum 4:3.
Crossref
Crossref
Tania Jain, Christopher Croswell, Varinia Urday-Cornejo, Reda Awali, Jessica Cutright, Hossein Salimnia, Harsha Vardhan Reddy Banavasi, Alyssa Liubakka, Paul Lephart, Teena Chopra, Sanjay G. Revankar, Pranatharthi Chandrasekar & George Alangaden. (2016) Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains. Biology of Blood and Marrow Transplantation 22:1, pages 157-163.
Crossref
Crossref
Nicole M. Boyle, Amalia Magaret, Zach Stednick, Alex Morrison, Susan Butler-Wu, Danielle Zerr, Karin Rogers, Sara Podczervinski, Anqi Cheng, Anna Wald & Steven A. Pergam. (2015) Evaluating risk factors for Clostridium
difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrobial Resistance and Infection Control 4:1.
Crossref
Crossref
Massimo Sartelli, Mark A. Malangoni, Fikri M. Abu-Zidan, Ewen A. Griffiths, Stefano Di Bella, Lynne V. McFarland, Ian Eltringham, Vishal G. Shelat, George C. Velmahos, Ciarán P. Kelly, Sahil Khanna, Zaid M. Abdelsattar, Layan Alrahmani, Luca Ansaloni, Goran Augustin, Miklosh Bala, Frédéric Barbut, Offir Ben-Ishay, Aneel Bhangu, Walter L. Biffl, Stephen M. Brecher, Adrián Camacho-Ortiz, Miguel A. Caínzos, Laura A. Canterbury, Fausto Catena, Shirley Chan, Jill R. Cherry-Bukowiec, Jesse Clanton, Federico Coccolini, Maria Elena Cocuz, Raul Coimbra, Charles H. Cook, Yunfeng Cui, Jacek Czepiel, Koray Das, Zaza Demetrashvili, Isidoro Di Carlo, Salomone Di Saverio, Irina Magdalena Dumitru, Catherine Eckert, Christian Eckmann, Edward H. Eiland, Mushira Abdulaziz Enani, Mario Faro, Paula Ferrada, Joseph Derek Forrester, Gustavo P. Fraga, Jean Louis Frossard, Rita Galeiras, Wagih Ghnnam, Carlos Augusto Gomes, Venkata Gorrepati, Mohamed Hassan Ahmed, Torsten Herzog, Felicia Humphrey, Jae Il Kim, Arda Isik, Rao Ivatury, Yeong Yeh Lee, Paul Juang, Luis Furuya-Kanamori, Aleksandar Karamarkovic, Peter K Kim, Yoram Kluger, Wen Chien Ko, Francis D. LaBarbera, Jae Gil Lee, Ari Leppaniemi, Varut Lohsiriwat, Sanjay Marwah, John E. Mazuski, Gokhan Metan, Ernest E. Moore, Frederick Alan Moore, Carl Erik Nord, Carlos A. Ordoñez, Gerson Alves Pereira Júnior, Nicola Petrosillo, Francisco Portela, Basant K. Puri, Arnab Ray, Mansoor Raza, Miran Rems, Boris E. Sakakushev, Gabriele Sganga, Patrizia Spigaglia, David B. Stewart, Pierre Tattevin, Jean Francois Timsit, Kathleen B. To, Cristian Tranà, Waldemar Uhl, Libor Urbánek, Harry van Goor, Angela Vassallo, Jean Ralph Zahar, Emanuele Caproli & Pierluigi Viale. (2015) WSES guidelines for management of Clostridium difficile infection in surgical patients. World Journal of Emergency Surgery 10:1.
Crossref
Crossref
Daniel R. Knight, Briony Elliott, Barbara J. Chang, Timothy T. Perkins & Thomas V. Riley. (2015) Diversity and Evolution in the Genome of Clostridium difficile. Clinical Microbiology Reviews 28:3, pages 721-741.
Crossref
Crossref
Michael C. Abt, Brittany B. Lewis, Silvia Caballero, Huizhong Xiong, Rebecca A. Carter, Bože Sušac, Lilan Ling, Ingrid Leiner & Eric G. Pamer. (2015) Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell Host & Microbe 18:1, pages 27-37.
Crossref
Crossref
Daniel R Knight, Julie Hart, Nicholas G Gottardo, David W Eyre, Derrick W Crook & Thomas V Riley. (2015) Two cases of Clostridium difficile infection in unrelated oncology patients attributable to a single clone of C. difficile PCR ribotype 126. JMM Case Reports 2:3.
Crossref
Crossref
Analia Rodríguez Garzotto, Antonio Mérida García, Nerea Muñoz Unceta, M. Mar Galera Lopez, M. Ángeles Orellana-Miguel, C. Vanesa Díaz-García, Susana Cortijo-Cascajares, Hernán Cortes-Funes & M. Teresa Agulló-Ortuño. (2014) Risk factors associated with Clostridium difficile infection in adult oncology patients. Supportive Care in Cancer 23:6, pages 1569-1577.
Crossref
Crossref
Justine Jou, John Ebrahim, Frances S. Shofer, Keith W. Hamilton, John Stern & Jennifer H. Han. (2015)
Environmental Transmission of
Clostridium difficile
: Association Between Hospital Room Size and
C. difficile
Infection
. Infection Control & Hospital Epidemiology 36:5, pages 564-568.
Crossref
Crossref
Si-Lan Gu, Yun-Bo Chen, Tao Lv, Xue-wu Zhang, Ze-Qing Wei, Ping Shen & Lan-Juan Li. (2015) Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China. Journal of Medical Microbiology 64:3, pages 209-216.
Crossref
Crossref
Wei-Jia Fang, Da-Zhi Jing, Yun Luo, Cai-Yun Fu, Peng Zhao, Jiong Qian, Bing-Ru Tian, Xiao-Gang Chen, Yu-Long Zheng, Yi Zheng, Jing Deng, Wei-Hua Zou, Xue-Ren Feng, Fan-Long Liu, Xiao-Zhou Mou & Shu-Sen Zheng. (2014) Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China. BMC Infectious Diseases 14:1.
Crossref
Crossref
Young Kyung Yoon, Min Ja Kim, Jang Wook Sohn, Hye Suk Kim, Yoon Ji Choi, Jung Sun Kim, Seung Tae Kim, Kyong Hwa Park, Seok Jin Kim, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim & Yong Park. (2014) Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy. Supportive Care in Cancer 22:8, pages 2039-2048.
Crossref
Crossref
Mohamad El-Zaatari, Yu-Ming Chang, Min Zhang, Matthew Franz, Andrew Shreiner, Andrew J. McDermott, Koenraad F. van der Sluijs, René Lutter, Helmut Grasberger, Nobuhiko Kamada, Vincent B. Young, Gary B. Huffnagle & John Y. Kao. (2014)
Tryptophan Catabolism Restricts IFN-γ–Expressing Neutrophils and
Clostridium difficile
Immunopathology
. The Journal of Immunology 193:2, pages 807-816.
Crossref
Crossref
Sapna R Parmar, Valkal Bhatt, Jie Yang, Qiao Zhang & Michael Schuster. (2013)
A retrospective review of metronidazole and vancomycin in the management of
Clostridium difficile
infection in patients with hematologic malignancies
. Journal of Oncology Pharmacy Practice 20:3, pages 172-182.
Crossref
Crossref
Lilian M. Abbo & Ella J. Ariza-Heredia. (2014) Antimicrobial Stewardship in Immunocompromised Hosts. Infectious Disease Clinics of North America 28:2, pages 263-279.
Crossref
Crossref
Teresa R. Zembower. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients
43
89
.
Daryl D. DePestel & David M. Aronoff. (2013)
Epidemiology of
Clostridium difficile
Infection
. Journal of Pharmacy Practice 26:5, pages 464-475.
Crossref
Crossref
Glenn S Tillotson & Karl WeissNuttanun SuramaethakulTeena Chopra. 2013.
Clostridium difficile
: New Challenges for an Old Foe
.
Clostridium difficile
: New Challenges for an Old Foe
6
18
.
Oliver A. CornelyMark A. MillerBruno FantinKathleen MullaneYin KeanSherwood Gorbach. (2013)
Resolution of
Clostridium difficile
–Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
. Journal of Clinical Oncology 31:19, pages 2493-2499.
Crossref
Crossref
Burnham D. Carey-Ann & Karen C. Carroll. (2013) Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories. Clinical Microbiology Reviews 26:3, pages 604-630.
Crossref
Crossref
John F. Pohl. (2012) Clostridium difficile infection and proton pump inhibitors. Current Opinion in Pediatrics 24:5, pages 627-631.
Crossref
Crossref
David B. Stewart, Emmanuel Yacoub & Junjia Zhu. (2012) Chemotherapy Patients with C. difficile Colitis Have Outcomes Similar to Immunocompetent C. difficile Patients. Journal of Gastrointestinal Surgery 16:8, pages 1566-1572.
Crossref
Crossref
Frank P. Tverdek, Kenneth V. RolstonRoy F. Chemaly. (2012) Antimicrobial Stewardship in Patients with Cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:8, pages 722-734.
Crossref
Crossref
Paul J. Collini, Martijn Bauer, Ed Kuijper & David H. Dockrell. (2012) Clostridium difficile infection in HIV-seropositive individuals and transplant recipients. Journal of Infection 64:2, pages 131-147.
Crossref
Crossref
Matthias G Hautmann, Matthias Hipp & Oliver Kölbl. (2011) Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?. Radiation Oncology 6:1.
Crossref
Crossref